SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Aas K. The problem of allergen extracts and control solutions used in nasal and bronchial provocation tests. Allergol Immunopathol VI, 267, 976.
  • 2
    Advances in oral asthma therapy. Royal Society of Medicine Services Ltd., London , 1987.
  • 3
    Amaducci S, et al. Protocollo per l'esecuzione dei test di provocazione bronchiale aspecifica. Fisiopat Respir 3, 315, 1982.
  • 4
    Baltes EL. Pharmacokinetics of Cetirizine in animal species and in man. A new era in allergo therapy. Brussels Symposium, March 27–30, pp. 4550, 1987.
  • 5
    Balzano G, Schiano M, Cocco G, Melillo G. Preliminary studies on bronchial provocation with grass pollen extract administered as powder. In MelilloG, CoccoG, CentanniG, (eds): The use of allergen in powder form for provocation tests and for local immunotherapy in allergic asthma; from the Workshop held in the framework of the XIII Congress EAACI, Budapest 5–10 May 1986, pp. 6876, Forum Editoriale, Naples, 1986.
  • 6
    Boner AL, Bennati D, Vallone G, Richelli C, Falagiani P. Specificallergen challenge with freeze-dried D. pieronyssinus (Melillo-method): Its correlation with skin test, RAST results and clinical history in asthmatic children. In MelilloG, CoccoG, CentanniG, (eds): The use of allergen in powder form for provocation tests and for local immunotherapy in allergic asthma; from the Workshop held in the framework of the XIII Congress EAA-CI, Budapest 5–10 May 1986, pp. 3746, Forum Editoriale, Naples, 1986.
  • 7
    Booij-Noord H, Orie NGH, De Vries K. Immediate and late bronchial obstructive reactions to inhalation of house dust mite and protective effect of disodium cromoglycate and prednisone. J Allergy Clin Immunol 48, 334, 1971.
  • 8
    Bryant DH, Burns NW. Bronchial histamine reactivity. Its relationship to the reactivity of the bronchi to allergens. Clin Allergy 6, 523532, 1976.
  • 9
    Canavagh MJ, Broncky EA, Buckley JM. Clinical value of bronchial provocation testing in childhood asthma. J Allergy Clin Immunol 59, 41, 1977.
  • 10
    Centanni S, Abraham WM, Allegra L. Specific bronchoconstriction in allergic sheep with a new preparation of allergen in powder (summary). In MelilloG, CoccoG, CentanniG, (eds): The use of allergen in powder form for provocation tests and for local immunotherapy in allergic asthma; from the Workshop held in the framework of the XIII Congress EAACI, Budapest May 5–10 1986, pp. 2223, Forum Editoriale, Naples , 1986.
  • 11
    Chai H, Farr RS, Froehlich LA, et al. Standardization of bronchial inhalation challenge procedures. J Allergy Clin Immunol 56, 322327, 1975.
  • 12
    Chapman PH, Rawliss MD. A randomised single-blind study of astemizole and chlorferiramine in normal volunteers. Br J Clin Pharmacol 13, 593P (abstract) 1982.
  • 13
    Cocco G, Liccardi G, Cavaliere C, et al. Technique and results of a new provocation method. In MelilloG, CoccoG, CentanniG (eds). The use of allergen in powder form for provocation tests and for local immunotherapy in allergic asthma; from the Workshop held in the framework of the XIII Congress EAACI, Budapest May 5–10 1986, pp. 2428, Forum Editoriale, Naples , 1986.
  • 14
    Cockroft DW. Determinants of allergen-induced asthma: dose of allergen, circulating IgE antibody concentration and bronchial responsiveness to inhaled histamine. Am Rev Res Respir Dis 120, 10531058, 1979.
  • 15
    Cockroft DW. Bronchialinhalation tests. II Measurement of allergen (and occupational) bronchial responsiveness. Ann Allergy 59, 8998, 1987.
  • 16
    Coekroft DW, Killian DN, Mellon JJA, Hargreave FE. Bronchial reactivity to inhaled histamine. A method and clinical survey. Clin Allergy 7, 235243, 1977.
  • 17
    Cockeroft DW, Murdock KY. Comparative effects of inhaled salbutamol, sodium cromoglycate, and beclomethasone diproprionate on allergen-induced early asthmatic responses, late asthmatic responses, and increased bronchial responsiveness to histamine. J Allergy Clin Immunol 79, 73440, 1987.
  • 18
    Crescioli S, Boschetto P, Broseghini C, Maestrelli P, Mapp C, Fabbri L. Standardization of a new method for bronchoprovocation with micronized powder of Dermatophagoides pteronyssinus (DPT) administered via spin-haler. In MelilloG, CoccoG, Centanni, G, (eds): The use of allergen in powder form for provocation tests and for local immunotherapy in allergic asthma; from the Workshop held in the framework of the XIII Congress EAACI, Budapest May 5–10 1986, Forum Editoriale, pp. 2930, Naples , 1986.
  • 19
    Cropp GJ, Bernstein IL, Boushey, HA Jr, et al. Guidelines for bronchial inhalation challenges with pharmacologic and antigenic agents. ATS News Spring 11, 1980.
  • 20
    Dahl R, Johansson SA. Importance of duration of treatment with inhaled budesonide on immediate and late reaction. Eur J Respir Dis 63 (Suppl 122), 8283, 1982.
  • 21
    Dreborg S. Theskin prick test. Methodologic studies and clinical applications. Linkoping University Medical Dissertation No. 237, 1148, 1987.
  • 22
    Dreborg S. Skinprick test. An update. Folia Allergol Immunol Clin 35, 311, 1988.
  • 23
    Dreborg S. Bronchial provocation tests with biologically standardized allergenic preparations. In MelilloG, NormanPS, MaroneG (eds.). Clinical Immunology vol. 2, Respiratory allergy, pp. 185191, B.C. Decker Inc, Toronto , 1989.
  • 24
    Dreborg S, Basomba A, Belin L, et al. Biological equilibration of allergenic preparations. Methodological aspects and reproducibility. Clin Allergy 17, 537550, 1987.
  • 25
    Eiser NM, Kerrebijn KF, Quanjer PH. Guidelines for standardization of bronchial challenges with (nonspecific) bronchoconstricting agents. Bull Eur Physiopathol Respir 19, 495514, 1983.
  • 26
    Engstrom I. The bronchial provocation test and criteria for positive reaction. Allergy 35, 256258, 1980.
  • 27
    Falagiani P, Butti C. Mite allergen in powder. Technical problems. In MelilloG, CoccoG, CentanniG, (eds): The use of allergen in powder form for provocation tests and for local immunotherapy in allergic asthma; from the Workshop held in the framework of the XIII Congress EAACI, Budapest May 5–10 1986 pp. 1521, Forum Editoriale, Naples , 1986.
  • 28
    Filderman RB, Rosen LJ. Comparison of onset and offset of inhibition of antigen induced skin wealing of Seldane (Terfenadine), Hismanal (Astemizole) and placebo. J Allergy Clin Immunol 79, 190, 1987.
  • 29
    Frølund L, Madsen F, Gerner Svendsen VG, Weeke B. Reproducibility of standard bronchial allergen provocation test. Allergy 41, 3036, 1986.
  • 30
    Frølund L, Madsen F, Svendsen VG, Weeke B. Bronchial allergen challenge: Comparison between two different methods of provocation. Clin Allergy 17, 437448, 1987.
  • 31
    Grieco MH. Double blind crossover study of cromolyn sodium inhibition of aerosol antigen challenge. chest 61, 432, 1972.
  • 32
    Hasegawa J. Pharmacokinetic and biopharmaceutical studies on Azelatine hydrochloride in beagle dogs by quantitative selected-ion monitoring. Arzheim, Forsch/Drug Res 31, 12151220, 1981.
  • 33
    Herxheimer H. Antihistamine in bronchial asthma. Med J 4, 901, 1949.
  • 34
    Heykants J. Dose-proportionality, bioavailability, and steady-state kinetics of astemizole in man. Drug Development Res 8, 7178, 1986.
  • 35
    Holgate, ST (ed). Astemizole. A review of clinical experiments. ADIS Press International Ltd., Manchester , 1988.
  • 36
    Howarth P, Durham SR, Lee T, Kay AB. Influence of albuterol, cromolyn sodium and ipratropium bromide on the airway and circulatory mediator responses to allergen bronchial provocation in asthma. Am Rev Respir Dis 132, 986992, 1985.
  • 37
    Ingemann L, Formgren H, Løwenstein H, Ipsen H. The use of a reference allergenic extract in the evaluation of allergen products. Allergy 40, 273281, 1985.
  • 38
    Kestern W. Protektive Wirkung von Ipratropium-bromide (Sch 1000) bei akuten Broncokonstriktionen durch Allergeninhaltion. Respiration 31, 412, 1974.
  • 39
    Killian D. Factors in allergen induced asthma: Relevance of the intensity of the airway allergic reaction and non-specific bronchial reactivity. Clin Allergy 2, 619, 1976.
  • 40
    Lind P, Weeke B, Løwenstein H. A reference allergen preparation of the house dust mite D. pteronyssinus produced from whole mite culture. A part of the DAS 76 study. Allergy 39, 259274, 1984.
  • 41
    Løwenstein H. Physico-chemical and immunochemical methods for the control and quality of allergenic extracts. In Kurth, T, (ed): Regulatory control and standardization of allergenic extracts. Proceedings from First International Paul Ehrlich Seminar, pp. 122132, Gustav Fischer Verlag, Stuttgart , New York , 1980.
  • 42
    Løwenstein H. Selection of reference preparations. IUIS reference preparation. In Kurth, R, (ed): Regulatory control and standardization of allergenic extracts. Proceedings from Fifth International Paul Ehrlich Seminar, pp. 7578, Gustav Fisher Verlag, Stuttgart , New York , 1987.
  • 43
    Løwenstein H, Lind P, Weeke B. Identification and clinical significance of allergenic molecules of cat origin. Allergy 40, 430441, 1985.
  • 44
    Melillo G. Bronchial challenge with a micronized, freeze-dried extract administered as a powder by a special turboinhaler. In MelilloG, CoccoG, CentanniG, (eds): The use of allergen in powder form for provocation tests and for local immunotherapy in allergic asthma; from the Workshop held in the framework of the XIII Congress EAACI, Budapest May 5–10 1986, pp: 314, Forum Editoriale, Naples , 1986.
  • 45
    Melillo G. Allergen inhalation challenge with a micronized, freeze-dried extract administered as a powder by a powder-inhaler. In MelilloG, NormanPS, MaroneG, (eds): Clinical immunology vol. 2, Respiratory allergy, pp. 207213, B.C. Decker Inc., Toronto , 1989.
  • 46
    Millqvist E. Workshop on antiallergic drug Cong EAACI, Rome 1983. Allergy Observer 1, 1, 1984.
  • 47
    Mosbech H, et al. House dust mite asthma. Allergy 42, 456463, 1987.
  • 48
    Nordic Council on Medicines. Registration of allergen preparations. Nordic Guidelines. NLN Publications, No. 23, 2nd ed. Uppsala, 1–34, 1989.
  • 49
    Norman PS. International Units. In KurthR, (ed): Regulatory control and standardization of allergenic extracts. Proceedings from Fifth International Paul Ehrlich Seminar, pp. 175182, Gustav Fisher Verlag, Stuttgart , New York , 1987.
  • 50
    Nyberg L, Wood C. Advances in terbutalin pharmacokinetics. Eur. J Respir Dis 65, Suppl. 134, 1984.
  • 51
    Orehek J, Gayrard P, Grimaud C, Charpin J. Broncho-constriction provoquée par inhalation d'allergéne dans l'asthme: effet antagoniste d'un anticholinergic de synthése. Bull Physiopathol Respir (Nancy) 11/193, 1975.
  • 52
    Patriarca G, Romano A, Nucera E, et al. A multicentre investigation on bronchial inhalation challenge with hypoinhal method. In MelilloG, CoccoG, CentanniG, (eds): The use of allergen in powder form for provocation tests and for local immunotherapy in allergic asthma; from the Workshop held in the framework of the XIII Congress EAACI, Budapest 5–10 May 1986, pp. 3036, Forum Editoriale, Naples , 1986.
  • 53
    Pawels R, Van der Straeten M. Human pharmacokinetics of glucocorticoids. Eur J Respir Dis 63 (Suppl 122): 8283, 1982.
  • 54
    PepysJ, Frankland, AW (eds). Symposium of disodium cromoglycate in allergic airway disease. Butterworth, London , 1970.
  • 55
    Phillips MJ, Oilier S, Gould CAL, Davies RJ. Effect of antihistamines and antiallergic drugs on responses to allergen and histamine provocation tests in asthma. Thorax 39, 345351, 1984.
  • 56
    Pinto Mendes JA, Fernandes AM, Ribeiro MI, Paiva de Carvalho JH, Cardoso Oliveira LA, Robalo Cordeiro AJA. Bronchial provocation with Melillo method compared to the conventional method. In MelilloG, CoccoG, CentanniG, (eds): The use of allergen in powder form for provocation tests and for local immunotherapy in allergic asthma; from the Workshop held in the framework of the XIII Congress EAACI, Budapest 5–10 May. 1986, pp. 6167, Forum Editoriale; Naples , 1986.
  • 57
    Pipkorn U. Pharmacological influence of antiallergic medication or) in vivo allergen testing. Allergy 43, 8186, 1988.
  • 58
    Radwinski E. Multiple dose pharmacokinetics of loratadine (Abstract) American college of Clinical Pharmacology. Philadelphia , October 1986.
  • 59
    Rizzo A, Rizzo JA. Specific bronchial provocation tests in adults with a new technique: cumulative method. In MelilloG, CoccoG, Centanni, G, (eds): The use of allergen in powder, form for provocation tests and for local immunotherapy in allergic asthma; from the Workshop held in the framework of the XIII Congress EAACI, Budapest 5–10 May 1986, pp. 4760, Forum Editoriale, Naples , 1986.
  • 60
    Rocchiccioli KMS, Riley PA. Clinical pharmacology of Nedocromil sodium. Drugs 37 (Suppl. 1), 123126, 1989.
  • 61
    Roman IJ. Suppression of histamine-induced wheal response by loratadine (SCH 29851) over 28 days in man. Ann Allergy 57, 253256, 1986.
  • 62
    Rosenthal RR. The emerging role of broncho provocation. J Allergy Clin Immunol 6, 564568, 1979.
  • 63
    Rossoni G. Bronchodilating activity of mequitazine. Arch Int Pharmacodyn 268, 128140, 1984.
  • 64
    Schiano M, Cocco G, Balzano G, D'Agostino F, Melillo G. Nasal provocation with allergens in powder. In MelilloG, CoccoG, CentanniG, (eds): The use of allergen in powder form for provocation tests and for local immunotherapy in allergic asthma; from the Workshop held in the framework of the XIII Congress EAACI, Budapest 5–10 May 1986, pp. 7781, Forum Editoriale, Naples , 1986.
  • 65
    Schiller IVV, Lowel FC. The effect of drugs in modifying the response of asthmatic subjects to inhalation of pollen extracts determined by vital capacity measurements. Ann Allergy 5, 564, 1947.
  • 66
    Simons FE. The comparative pharmacokinetics of H1-receptor antagonists. Ann Allergy 59, 2024, 1987.
  • 67
    Spector S, Farr R. Bronchial inhalation challenge with antigens. J Allergy Clin Immunol 64, 580586, 1979.
  • 68
    Townley RJ, Dennis M, Itkin IH. Comparative action of acetyl-beta-methylcholine histamine and pollen antigens in subjects with hay fever and patients with bronchial asthma. J Allergy 36, 121, 1965.
  • 69
    Townley RJ, Hopp RJ. Inhalation methods for the study of airway responsiveness. J Allergy Clin Immunol 80, 111124, 1987.
  • 70
    Turkeltaub PC. Assignment of bioequivalent Allergy Units based on biological standardization methods. In KurthR, (ed): Regulatory control and standardization of allergenic extracts. Proceedings from Fifth International Paul Ehrlich Seminar, pp. 1940 Gustav Fisher Verlag, Stuttgart , New York , 1987.
  • 71
    Wütrich R, et al. The protective effect of a new oral anti-asthma agent (Ketotifene). against experimentally induced bronchospasm. Int J Clin Pharmacol Biopharm 16, 424, 1978.
  • 72
    Uzan A, Gueremy C, Le Fur G. Absorption, distribution et éxcretion de la (CXiinuclidinyl-3 methyl)-10 phénotiazine (LM 209), un nouvel anti-allergic. Xenobiotica 6, 633648, 1976.